
Context Therapeutics Inc.
Context Therapeutics Inc. (CNTX)
WebsitePrice
Market cap
Next catalystQ1 2027: anticipated Phase 1b expansion, informed by Phase 1a resultsCTIM-76 — Phase 1a dose escalation and planned Phase 1b expansion · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved